|
Report Date : |
23.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
WHITE MEDICAL CO LTD |
|
|
|
|
Registered Office : |
Daiichi Bldg 3F, 5-48-2 Higashi-Nippori Arakawaku |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2013 |
|
|
|
|
Date of Incorporation : |
January 1997 |
|
|
|
|
Com. Reg. No.: |
0115-01-008723 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Imports and wholesales ophthalmic instruments & surgery for
cataract, dry eye, other, disposable supplies, other (--100%) |
|
|
|
|
No of Employees : |
12 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
YEN 11.1 MILLION |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
JAPAN - ECONOMIC OVERVIEW
In the years following World
War II, government-industry cooperation, a strong work ethic, mastery of high technology,
and a comparatively small defense allocation (1% of GDP) helped Japan develop a
technologically advanced economy. Two notable characteristics of the post-war
economy were the close interlocking structures of manufacturers, suppliers, and
distributors, known as keiretsu, and the guarantee of lifetime employment for a
substantial portion of the urban labor force. Both features are now eroding
under the dual pressures of global competition and domestic demographic change.
Japan's industrial sector is heavily dependent on imported raw materials and
fuels. A small agricultural sector is highly subsidized and protected, with
crop yields among the highest in the world. While self-sufficient in rice
production, Japan imports about 60% of its food on a caloric basis. For three
decades, overall real economic growth had been spectacular - a 10% average in
the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth
slowed markedly in the 1990s, averaging just 1.7%, largely because of the after
effects of inefficient investment and an asset price bubble in the late 1980s
that required a protracted period of time for firms to reduce excess debt,
capital, and labor. Modest economic growth continued after 2000, but the
economy has fallen into recession three times since 2008. A sharp downturn in
business investment and global demand for Japan's exports in late 2008 pushed
Japan into recession. Government stimulus spending helped the economy recover
in late 2009 and 2010, but the economy contracted again in 2011 as the massive
9.0 magnitude earthquake and the ensuing tsunami in March disrupted
manufacturing. The economy has largely recovered in the two years since the
disaster, but reconstruction in the Tohoku region has been uneven. Prime
Minister Shinzo ABE has declared the economy his government's top priority; he
has overturned his predecessor's plan to permanently close nuclear power plants
and is pursuing an economic revitalization agenda of fiscal stimulus, monetary
easing, and structural reform. Japan joined the Trans Pacific Partnership
negotiations in 2013, a pact that would open Japan's economy to increased
foreign competition and create new export opportunities for Japanese
businesses. Measured on a purchasing power parity (PPP) basis that adjusts for
price differences, Japan in 2013 stood as the fourth-largest economy in the
world after second-place China, which surpassed Japan in 2001, and third-place
India, which edged out Japan in 2012. The new government will continue a
longstanding debate on restructuring the economy and reining in Japan's huge
government debt, which is exceeding 230% of GDP. To help raise government
revenue and reduce public debt, Japan decided in 2013 to gradually increase the
consumption tax to a total of 10% by the year 2015. Japan is making progress on
ending deflation due to a weaker yen and higher energy costs, but reliance on
exports to drive growth and an aging, shrinking population pose other major
long-term challenges for the economy.
|
Source
: CIA |
WHITE MEDICAL CO
LTD
KK White Medical
Daiichi Bldg 3F, 5-48-2 Higashi-Nippori Arakawaku Tokyo 116-0012 Japan
Tel: 03-3802-0655
URL: http://www.whitemedical.co.jp
E-Mail address: white1@sepia.ocn.ne.jp
ACTIVITIES: Import, wholesale of ophthalmic
instruments, surgery equipment, other
BRANCHES: Fukuoka
OFFICERS: TOSHIO TANAKA, PRES
Yen Amount: In million Yen,
unless otherwise stated
FINANCES FAIR A/SALES Yen 600 M
PAYMENTS NO COMPLAINTS CAPITAL Yen 17 M
TREND STEADY WORTH Yen 129 M
STARTED 1997 EMPLOYES 12
COMMENT: TRADING
FIRM SPECIALIZING IN OPHTHALMIC INSTRUMENTS.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS
ENGAGEMENTS.
MAX CREDIT
LIMIT: ESTIMATED AT YEN 11.1 MILLION, ON 30 DAYS NORMAL TERMS.
The subject company was established by Toshio Tanaka in order to make
most of his experience in the subject line of business. This is a trading firm specializing in import
and wholesale of ophthalmic instruments, surgery equipment, disposable
supplies, other. Clients include
hospitals, laboratories, universities, other.
Financials are disclosed only partially.
Profits re not disclosed and only estimated.
The sales volume for Mar/2013 fiscal term amounted to Yen 600 million, a
similar amount in the previous term. The
net profit is estimated posted at Yen 10 million, similarly in the previous
period.
For the term that ended Mar 2014 the net profit was projected at Yen 15
million, on a 5% rise in turnover, to Yen 630 million. Weaker Yen may have raised earnings in Yen
terms. Final results are yet to be
released.
The financial situation is considered FAIR and good for ORDINARY
business engagements. Max credit limit
is estimated at Yen 11.1 million, on 30 days normal terms.
Date Registered: Jan
1997
Regd No.: 0115-01-008723 (Tokyo-Arakawaku)
Legal Status: Limited Company (Kabushiki
Kaisha)
Authorized: 1,360 shares
Issued:
340 shares
Sum: Yen
17 million
Major shareholders
(%): Toshio Tanaka (100)
Nothing detrimental is known as to his commercial morality of
executives.
Activities: Imports and
wholesales ophthalmic instruments & surgery for cataract, dry eye, other,
disposable supplies, other (--100%)
Clients: [Mfrs,
wholesalers] Takeyama Co, Mutow Co, Yagami Co, Nippon Ganka Iryo Center, other to
hospitals, laboratories, other
No. of accounts: 300
Domestic areas of activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Scican, Eagle Vision, Accutome Inc, other
Payment record: No Complaints
Location: Business area in
Tokyo. Office premises at the caption
address are leased and maintained satisfactory.
Bank References:
Johoku Shinkin Bank (Nippori-Ekimae)
SMBC (Ueno)
Relations: Satisfactory
(In Million Yen)
|
Terms Ending: |
|
31/03/2014 |
31/03/2013 |
31/03/2012 |
31/03/2011 |
|
Annual Sales |
|
630 |
600 |
600 |
600 |
|
Recur. Profit |
|
.. |
.. |
.. |
.. |
|
Net Profit |
|
15 |
10 |
10 |
10 |
|
Total Assets |
|
|
N/A |
N/A |
N/A |
|
Net Worth |
|
|
129 |
119 |
109 |
|
Capital, Paid-Up |
|
|
17 |
17 |
17 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
5.00 |
0.00 |
0.00 |
0.00 |
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
|
.. |
.. |
.. |
|
N.Profit/Sales |
|
2.38 |
1.67 |
1.67 |
1.67 |
Notes:
Financials are only partially disclosed.
Profits are not precisely disclosed and only estimated.
Forecast (or estimated) figures for the 31/03/2014 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.77 |
|
|
1 |
Rs.100.72 |
|
Euro |
1 |
Rs.80.55 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.